CAR T-Cell Therapy Yields High Response Rate in Aggressive Lymphoma – Cancer Network
|
CAR T-Cell Therapy Yields High Response Rate in Aggressive Lymphoma
Cancer Network In this video, Frederick Locke, MD, of the Moffitt Cancer Center in Tampa, Florida, discusses results of the ZUMA-1 trial, which tested chimeric antigen receptor (CAR) T-cell therapy with axicabtagene ciloleucel (axi-cel; KTE-C19) in this patient … |
